EUVIMEDEUVIMED entdecken
Crossref

Impact of systemic tranexamic acid on postoperative drainage in large-volume reduction mammaplasty

Carolin Wachtel, Jens Rothenberger, Ines Ana Ederer, Lara Küenzlen, Andrej Wehle, Jochen Souquet, Ulrich Michael Rieger

Journal of Plastic, Reconstructive & Aesthetic Surgery · 2026-08 · 119 · 243-251

DOI: 10.1016/j.bjps.2026.06.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026-08. Verfasst von Carolin Wachtel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Aesthetic Surgery, Reconstructive and Hand Surgery, Agaplesion Markus Hospital, Frankfurt am Main, Germany. Electronic addr…. Hauptthemen laut MEDLINE: Tranexamic Acid, Drainage, Mammaplasty, Antifibrinolytic Agents. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Optimizing clinical outcomes and postoperative recovery plays a key role in surgical procedures. We evaluated the effects of systemic tranexamic acid (TXA) administration on postoperative drainage in patients undergoing large-volume reduction mammaplasty. METHODS: A retrospective cohort analysis was performed by including 104 patients (208 breasts) who underwent large-volume reduction mammaplasty, defined as resection weights ≥ 500 g per breast. Overall, 59 patients (118 breasts) received intraoperative intravenous TXA, whereas 45 patients (90 breasts) served as a historic control cohort treated prior to routine TXA implementation. Postoperative drainage-related outcomes were assessed using time-dependent drain output (24 and 48 h), total drainage volume, and drainage duration. Furthermore, length of hospital stay, hemoglobin decline on the first postoperative day, bleeding-related complications, and thromboembolic events were evaluated as secondary outcomes. RESULTS: Systemic TXA administration was associated with lower postoperative drain output within the first 24 h, with statistically significant differences at 48 h (54 mL versus 80 mL, 32.5%) and in total drainage volume (68 mL versus 117 mL, 41.9%) per breast. Patients receiving TXA demonstrated a significantly shorter drainage duration and hospital stay (p < 0.0001). Absolute and relative hemoglobin decline did not differ between the groups. Bleeding-related complications were observed less frequently in the TXA group (1.7% versus 13.3%) and no thromboembolic events were observed in either group during the study period, although the number of events was low. CONCLUSION: Systemic administration of TXA in large-volume reduction mammaplasty is associated with reduced postoperative drainage, accompanied by shorter drain duration and length of hospital stay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidDrainageMammaplastyAntifibrinolytic AgentsHumansFemaleRetrospective StudiesAdultLength of StayMiddle AgedPostoperative HemorrhageBreastTreatment OutcomePostoperative Complications

Stichwörter der Autor:innen

Large-volume reduction mammaplastyPatient recoveryPostoperative drain volumeSurgical outcomeTranexamic acid

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Department of Plastic and Aesthetic Surgery, Reconstructive and Hand Surgery, Agaplesion Markus Hospital, Frankfurt am Main, Germany. Electronic address: carolin.wachtel@gmx.de.
  • Department of Plastic and Aesthetic Surgery, Reconstructive and Hand Surgery, Agaplesion Markus Hospital, Frankfurt am Main, Germany; Department of Plastic, Reconstructive and Aesthetic Surgery, Diakonie Hospital Bad Kr…
  • Department of Plastic and Aesthetic Surgery, Reconstructive and Hand Surgery, Agaplesion Markus Hospital, Frankfurt am Main, Germany; Department for Oral, Cranio-Maxillofacial and Facial Plastic Surgery, University Hosp…
  • Department of Plastic and Aesthetic Surgery, Reconstructive and Hand Surgery, Agaplesion Markus Hospital, Frankfurt am Main, Germany.
  • Department of Anesthesiology und Pain Medicine, Agaplesion Markus Hospital, Frankfurt am Main, Germany.

Zitieren

APA

Wachtel, C., Rothenberger, J., Ederer, I. A., Küenzlen, L., Wehle, A., Souquet, J., & Rieger, U. M. (2026). Impact of systemic tranexamic acid on postoperative drainage in large-volume reduction mammaplasty. Journal of Plastic, Reconstructive & Aesthetic Surgery, 119, 243-251. https://doi.org/10.1016/j.bjps.2026.06.014

Vancouver

Wachtel C, Rothenberger J, Ederer IA, Küenzlen L, Wehle A, Souquet J, et al. Impact of systemic tranexamic acid on postoperative drainage in large-volume reduction mammaplasty. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026;119:243-251. doi:10.1016/j.bjps.2026.06.014

BibTeX
@article{Wachtel2026,
  author = {Wachtel, Carolin and Rothenberger, Jens and Ederer, Ines Ana and Küenzlen, Lara and Wehle, Andrej and Souquet, Jochen and Rieger, Ulrich Michael},
  title = {Impact of systemic tranexamic acid on postoperative drainage in large-volume reduction mammaplasty},
  journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
  year = {2026},
  volume = {119},
  pages = {243--251},
  doi = {10.1016/j.bjps.2026.06.014}
}
Kostenlos starten →